There were no clinically significant changes in the drug efficacy indicators (fasting plasma glucose, C-peptide, insulin, proinsulin, glucagon, fasting body weight) at each time point after administration of all subjects compared with baseline. Each dose group There was no significant difference between them, and there was no significant difference between each administration group and the placebo group.